XML 92 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity
6 Months Ended
Feb. 27, 2014
Disclosure Text Block [Abstract]  
Equity
Equity

Changes in the components of equity were as follows:

 
 
Six Months Ended February 27, 2014
 
Six Months Ended February 28, 2013
 
 
Attributable to Micron
 
Noncontrolling Interests
 
Total Equity
 
Attributable to Micron
 
Noncontrolling Interests
 
Total Equity
Beginning balance
 
$
9,142

 
$
864

 
$
10,006

 
$
7,700

 
$
717

 
$
8,417

 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
1,089

 
33

 
1,122

 
(561
)
 
2

 
(559
)
Other comprehensive income (loss)
 
(4
)
 

 
(4
)
 
(1
)
 

 
(1
)
Comprehensive income (loss)
 
1,085

 
33

 
1,118

 
(562
)
 
2

 
(560
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Contribution from noncontrolling interests
 

 
49

 
49

 

 
10

 
10

Distributions to noncontrolling interests
 

 
(19
)
 
(19
)
 

 

 

Acquisition of noncontrolling interests in MMT
 
31

 
(167
)
 
(136
)
 

 

 

Capital and other transactions attributable to Micron
 
(974
)
 

 
(974
)
 
93

 

 
93

Ending balance
 
$
9,284

 
$
760

 
$
10,044

 
$
7,231

 
$
729

 
$
7,960



Micron Shareholders' Equity

Capped Calls

Issued and Outstanding Capped Calls: We have entered into a series of capped call transactions intended to reduce the effect of potential dilution upon conversion of our convertible notes which may be settled in shares or cash, at our election. The capped call transactions are considered capital transactions and the related cost was recorded as a charge to additional capital.

The following table presents information related to the issued and outstanding capped calls as of February 27, 2014.

Capped Calls
 

 
 
 
Strike Price(1)
 
Cap Price Range
 
Common Shares Covered
 
Value at Expiration(2)
 
Expiration Dates
 
 
Low
 
High
 
 
Minimum
 
Maximum
2031
 
Jul 2014
 -
Feb 2016
 
$
9.50

 
$
11.40

 
$
13.17

 
73

 
$

 
$
207

2032C
 
May 2016
 -
Nov 2017
 
9.80

 
14.26

 
15.69

 
56

 

 
307

2032D
 
Nov 2016
 -
May 2018
 
10.16

 
14.62

 
16.04

 
44

 

 
244

2033E
 
Jan 2018
 -
Feb 2018
 
10.93

 
14.51

 
14.51

 
27

 

 
98

2033F
 
Jan 2020
 -
Feb 2020
 
10.93

 
14.51

 
14.51

 
27

 

 
98

 
 
 
 
 
 
 
 
 
 
 
 
227

 
$

 
$
954

(1) 
Initial strike prices are subject to certain adjustments.
(2) 
Settlement in cash on the respective expiration dates would result in us receiving an amount ranging from zero, if the market price per share of our common stock is at or below the respective low strike price, to the respective maximum amount if the market price per share of our common stock is at or above the respective high cap price. If share settlement were elected, the number of shares repurchased would be determined by the value of the capped calls at the time of settlement divided by the share price on the settlement date. Settlement of the capped calls prior to the expiration dates may be for an amount less than the maximum value at expiration.

Accumulated Other Comprehensive Income (Loss)

The changes in accumulated other comprehensive income (loss) by component in the first six months of 2014 were as follows:

 
 
Cumulative Foreign Currency Translation Adjustments
 
Gains (Losses) on Derivative Instruments, Net
 
Gains (Losses) on Investments, Net
 
Pension Liability Adjustments
 
Total
August 29, 2013
 
$
44

 
$
21

 
$

 
$
(2
)
 
$
63

Other comprehensive income before reclassifications
 
(4
)
 
(2
)
 
4

 
1

 
(1
)
Amount reclassified out of accumulated other comprehensive income
 

 
(1
)
 
(2
)
 
1

 
(2
)
Tax effects
 

 
(1
)
 

 

 
(1
)
Other comprehensive income (loss)
 
(4
)
 
(4
)
 
2

 
2

 
(4
)
February 27, 2014
 
$
40

 
$
17

 
$
2

 
$

 
$
59



Noncontrolling Interests in Subsidiaries

As of
 
February 27, 2014
 
August 29, 2013
 
 
Noncontrolling Interest Balance
 
Noncontrolling Interest Percentage
 
Noncontrolling Interest Balance
 
Noncontrolling Interest Percentage
IMFT(1)
 
$
640

 
49.00
%
 
$
601

 
49.00
%
MP Mask(1)
 
93

 
49.99
%
 
92

 
49.99
%
MMT
 
21

 
1.24
%
 
155

 
11.11
%
Other
 
6

 
Various

 
16

 
Various

 
 
$
760

 
 
 
$
864

 
 
(1) Entity is a variable interest entity.

IMFT

Since its inception in 2006 through February 27, 2014, we have owned 51% of IMFT, a venture between us and Intel to manufacture NAND Flash memory products and certain emerging memory technologies, for the exclusive use of the members. IMFT is governed by a Board of Managers and the number of managers appointed by each member to the board varies based on the members' respective ownership interests, which is based on cumulative contributions to IMFT. The IMFT joint venture agreement extends through 2024 and includes certain buy-sell rights, commencing in 2015, pursuant to which Intel may elect to sell to us, or we may elect to purchase from Intel, Intel's interest in IMFT. If Intel elects to sell to us, we would set the closing date of the transaction within two years following such election and could elect to receive financing of the purchase price from Intel for one to two years from the closing date.

IMFT manufactures NAND Flash memory products using designs and technology we develop with Intel. We generally share with Intel the cost of product design, other NAND Flash R&D costs and R&D cost of certain emerging memory technologies. Our R&D expenses were reduced by reimbursements from Intel of $35 million and $64 million for the second quarter and first six months of 2014, respectively, and $34 million and $66 million for the second quarter and first six months of 2013, respectively.

We sell a portion of our products to Intel through our IMFT joint venture at long-term negotiated prices approximating cost. Sales of NAND Flash products to Intel under this arrangement were $104 million and $205 million for the second quarter and first six months of 2014, respectively, and $91 million and $190 million for the second quarter and first six months of 2013, respectively. Receivables from Intel for IMFT sales of NAND Flash products as of February 27, 2014 and August 29, 2013, were $62 million and $68 million, respectively.

The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets, excluding intercompany balances:

As of
 
February 27,
2014
 
August 29, 2013
Assets
 
 
 
 
Cash and equivalents
 
$
112

 
$
62

Receivables
 
70

 
76

Inventories
 
47

 
49

Other current assets
 
5

 
4

Total current assets
 
234

 
191

Property, plant and equipment, net
 
1,348

 
1,382

Other noncurrent assets
 
42

 
46

Total assets
 
$
1,624

 
$
1,619

 
 
 
 
 
Liabilities
 
 
 
 
Accounts payable and accrued expenses
 
$
93

 
$
88

Deferred income
 
8

 
9

Equipment purchase contracts
 
11

 
78

Current debt
 
6

 
6

Total current liabilities
 
118

 
181

Long-term debt
 
10

 
13

Other noncurrent liabilities
 
114

 
118

Total liabilities
 
$
242

 
$
312

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Our ability to access IMFT's cash and other assets through cash dividends, loans or advances, including to finance our other operations, is subject to agreement by Intel. Creditors of IMFT have recourse only to its assets and do not have recourse to any other of our assets.

The following table presents IMFT's distributions to and contributions from its shareholders:

 
 
Quarter Ended
 
Six Months Ended
 
 
February 27,
2014
 
February 28,
2013
 
February 27,
2014
 
February 28,
2013
IMFT distributions to Micron
 
$
10

 
$

 
$
10

 
$

IMFT distributions to Intel
 
10

 

 
10

 

Micron contributions to IMFT
 

 
10

 
51

 
10

Intel contributions to IMFT
 

 
10

 
49

 
10


MP Mask

In 2006, we formed a joint venture with Photronics to produce photomasks for leading-edge and advanced next generation semiconductors.  At inception and through February 27, 2014, we owned 50.01% and Photronics owned 49.99% of MP Mask. In connection with the formation of the joint venture, we received $72 million in 2006 in exchange for entering into a license agreement with Photronics, which is being recognized over the term of the 10-year agreement.  Deferred income and other noncurrent liabilities included an aggregate of $16 million and $19 million as of February 27, 2014 and August 29, 2013, respectively, related to this agreement. We purchase a substantial majority of the reticles produced by MP Mask pursuant to a supply arrangement.

Total MP Mask assets and liabilities included in our consolidated balance sheets were as follows:

As of
 
February 27,
2014
 
August 29, 2013
Current assets
 
$
37

 
$
26

Noncurrent assets (primarily property, plant and equipment)
 
209

 
182

Current liabilities
 
40

 
25

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Creditors of MP Mask have recourse only to the assets of MP Mask and do not have recourse to any other of our assets.

MMT

As a result of the acquisition of Elpida and MMT on July 31, 2013, noncontrolling interests in subsidiaries in our consolidated balance sheet included an approximate 11.11% ownership interest in MMT. In the second quarter of 2014, we purchased an additional 9.87% of MMT's outstanding common stock for $136 million. The purchase of substantially all of the shares was financed with a short-term loan from a seller. (See "Debt – Other Notes Payable" note.) As a result of the purchase of MMT shares, noncontrolling interest decreased by $167 million and additional capital increased by $31 million in the second quarter of 2014.